V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010231 | 310003417 | 1.6 | 102.5 | Palliative (P) | 2018-05-13 | 2018-05-21 | GEMCARBO | N | N | 310006162 | GEMCARBO |
| 310010233 | 310003431 | 1.66 | 60.6 | Palliative (P) | 2018-11-24 | 2018-12-17 | Bevacizumab 15mg/kg | N | N | 310006253 | BEVACIZUMAB |
| 310010234 | 310003434 | 1.57 | 47.1 | Palliative (P) | 2015-09-23 | 2015-09-26 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006261 | LIPOSOMAL DOXORUBICIN |
| 310010235 | 310003437 | 1.66 | 66 | Neo-adjuvant (N) | 2014-08-16 | 2014-09-01 | GEMCARBO | 2 | N | 310006265 | GEMCARBO |
| 310010236 | 310003440 | 1.63 | 66.8 | Adjuvant (A) | 2014-06-20 | 2014-06-27 | Bevacizumab | N | N | 310006270 | BEVACIZUMAB |
| 310010237 | 310003452 | 1.72 | 104.6 | Palliative (P) | 2017-04-06 | 2017-04-14 | Bevacizumab 7.5mg/kg | N | N | 310006281 | BEVACIZUMAB |
| 310010238 | 310007393 | 1.54 | 57.3 | Palliative (P) | 2017-10-11 | 2017-10-12 | CHOP - 21 days | N | N | 310006334 | CHOP |
| 310010239 | 310003465 | 1.96 | 78 | Palliative (P) | 2019-02-13 | 2019-02-19 | GEMCARBO | 02 | N | 310006354 | GEMCARBO |
| 310010240 | 310003468 | null | 82 | Palliative (P) | 2016-05-19 | 2016-05-22 | CARBOPLATIN + GEMCITABINE | 02 | N | 310006355 | GEMCARBO |
| 310010241 | 310010531 | 1.79 | 71.6 | Palliative (P) | 2016-07-03 | 2016-07-12 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE PREDNISOLONE | 02 | N | 310006392 | CHOP |
| 310010242 | 310003480 | 1.6 | 67.8 | Palliative (P) | 2018-02-06 | 2018-02-11 | Liposomal Doxorubicin (Myocet) | N | N | 310006394 | LIPOSOMAL DOXORUBICIN |
| 310010243 | 310007401 | 1.66 | 91.4 | Curative (C) | 2017-03-11 | 2017-03-11 | Trial Unspecified | 01 | N | 310006397 | TRIAL |
| 310010244 | 310011488 | 1.7 | 94.4 | Palliative (P) | 2018-10-05 | 2018-12-25 | Bevacizumab 7.5mg/kg | 02 | N | 310006435 | BEVACIZUMAB |
| 310010245 | 310009450 | 1.84 | 71.9 | Palliative (P) | 2019-06-17 | 2019-06-22 | GEMCARBO | 02 | N | 310006481 | GEMCARBO |
| 310010246 | 310003500 | 1.84 | 83.2 | Palliative (P) | 2014-02-10 | 2014-02-11 | GEMCARBO | 2 | N | 310006486 | GEMCARBO |
| 310010247 | 310003504 | 1.76 | 78 | Palliative (P) | 2015-04-14 | 2015-04-19 | Liposomal Doxorubicin (Caelyx) | N | N | 310006516 | LIPOSOMAL DOXORUBICIN |
| 310010248 | 310007413 | 1.74 | 87.2 | Palliative (P) | null | 2015-04-28 | Liposomal Doxorubicin (Caelyx) | null | null | 310006525 | LIPOSOMAL DOXORUBICIN |
| 310010249 | 310003508 | 1.61 | 56 | Palliative (P) | 2018-02-13 | 2018-05-10 | CHOP - 21 days | N | N | 310006540 | CHOP |
| 310010250 | 310003514 | 1.6 | null | Palliative (P) | 2014-03-07 | 2014-03-14 | GemCarbo Days 1+8 | N | null | 310006572 | GEMCARBO |
| 310010251 | 310007418 | 1.96 | 78.5 | Palliative (P) | null | 2018-06-22 | Liposomal Doxorubicin (Caelyx) | N | null | 310006575 | LIPOSOMAL DOXORUBICIN |
| 310010252 | 310003518 | 1.56 | 63.6 | Palliative (P) | 2014-07-03 | 2014-07-11 | GEMCARBO | 02 | N | 310006576 | GEMCARBO |
| 310010253 | 310007420 | 1.8 | null | Palliative (P) | 2015-05-16 | 2015-09-06 | GemCarbo Days 1+8 | 2 | null | 310006577 | GEMCARBO |
| 310010254 | 310003527 | 1.77 | 69.05 | Palliative (P) | 2018-01-07 | 2018-01-07 | CHOP | N | N | 310006620 | CHOP |
| 310010255 | 310003528 | 1.58 | 69.6 | Palliative (P) | 2017-08-03 | 2017-08-08 | CHOP | 02 | N | 310006623 | CHOP |
| 310010256 | 310003538 | 1.74 | 82.8 | Palliative (P) | 2017-08-23 | 2017-09-15 | GEMCARBO | 2 | null | 310006643 | GEMCARBO |
| 310010257 | 310003544 | 1.77 | 79.5 | Palliative (P) | 2019-04-05 | 2019-04-05 | Bevacizumab 7.5mg/kg | N | N | 310006675 | BEVACIZUMAB |
| 310010258 | 310007431 | 1.7 | 81.5 | Palliative (P) | 2016-03-17 | 2016-03-17 | Trial Unspecified | 01 | N | 310006679 | TRIAL |
| 310010259 | 310003553 | 1.57 | 96.4 | Curative (C) | 2016-10-16 | 2016-11-13 | Trial Unspecified | Y | N | 310006695 | TRIAL |
| 310010260 | 310003555 | 1.68 | 61.7 | Palliative (P) | 2015-02-04 | 2015-02-04 | Bevacizumab 15mg/kg | N | N | 310006718 | BEVACIZUMAB |
| 310010261 | 310003558 | 1.8 | 104 | Palliative (P) | null | 2014-09-24 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310006726 | LIPOSOMAL DOXORUBICIN |
| 310010262 | 310003574 | 1.71 | null | Palliative (P) | 2018-02-05 | 2018-02-08 | Trial Unspecified | 1 | N | 310006760 | TRIAL |
| 310010264 | 310003585 | 1.7 | 76.6 | Palliative (P) | 2015-03-31 | 2015-04-09 | GemCarbo Days 1+8 | 02 | N | 310006785 | GEMCARBO |
| 310010265 | 310003592 | 1.64 | 73.5 | Palliative (P) | 2018-08-18 | 2018-08-18 | Trial Unspecified | N | N | 310006795 | TRIAL |
| 310010266 | 310003597 | 1.66 | 51 | null | 2017-04-17 | 2017-04-25 | Trial Unspecified | N | N | 310006828 | TRIAL |
| 310010267 | 310009469 | 1.8 | 84.4 | Palliative (P) | 2014-04-12 | 2014-04-13 | CHEMO-T TRIAL | Y | N | 310006829 | TRIAL |
| 310010268 | 310003600 | null | 79.5 | Palliative (P) | 2019-02-12 | 2019-02-16 | CHOP - 21 days | N | N | 310006847 | CHOP |
| 310010269 | 310003600 | 1.7 | 82.6 | Palliative (P) | 2014-10-28 | 2014-11-03 | Bevacizumab 7.5mg/kg | 02 | N | 310006847 | BEVACIZUMAB |
| 310010271 | 310003609 | null | 77.1 | Palliative (P) | 2017-07-05 | 2017-10-03 | Bevacizumab 7.5mg/kg | N | N | 310006895 | BEVACIZUMAB |
| 310010272 | 310003612 | 1.67 | 95 | Curative (C) | 2014-12-09 | 2014-12-09 | Bevacizumab 7.5mg/kg | N | N | 310006907 | BEVACIZUMAB |
| 310010273 | 310003616 | null | null | null | 2015-04-10 | 2015-04-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310006908 | LIPOSOMAL DOXORUBICIN |
| 310010274 | 310003617 | 1.76 | 73 | Palliative (P) | 2016-05-24 | 2016-05-29 | CHOP - 21 days | N | N | 310006912 | CHOP |
| 310010275 | 310007457 | 1.74 | null | Adjuvant (A) | 2014-02-24 | 2014-04-05 | Bevacizumab 7.5mg/kg | N | N | 310006914 | BEVACIZUMAB |
| 310010276 | 310003620 | 1.68 | null | Palliative (P) | 2014-09-18 | 2015-10-10 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310006915 | LIPOSOMAL DOXORUBICIN |
| 310010277 | 310003622 | 1.87 | null | Palliative (P) | 2017-03-19 | 2017-03-20 | GemCarbo Days 1+8 | 2 | N | 310006928 | GEMCARBO |
| 310010278 | 310003628 | 1.7 | 65.7 | Adjuvant (A) | 2015-12-15 | 2015-12-16 | CHEMO-T TRIAL | 02 | N | 310006936 | TRIAL |
| 310010279 | 310003641 | 1.68 | 76.6 | Palliative (P) | 2015-07-09 | 2016-05-28 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310006986 | LIPOSOMAL DOXORUBICIN |
| 310010280 | 310009480 | 1.58 | 78 | Palliative (P) | 2018-05-02 | 2018-05-02 | Trial Unspecified | 01 | N | 310007023 | TRIAL |
| 310010281 | 310003646 | 1.73 | null | Palliative (P) | 2016-11-06 | 2016-11-19 | CARBOPLATIN + GEMCITABINE | N | N | 310007031 | GEMCARBO |
| 310010282 | 310010553 | null | 55.2 | Adjuvant (A) | 2016-12-12 | 2016-12-19 | CHOP - 21 days | 02 | N | 310007034 | CHOP |
| 310010283 | 310007472 | 1.7 | 95 | Adjuvant (A) | 2017-04-10 | 2017-04-14 | Bevacizumab 7.5mg/kg | N | N | 310007041 | BEVACIZUMAB |